ABSTRACT
Porphyromonas gingivalis is an oral bacterium commonly associated with periodontitis. P. gingivalis synthesizes sphingolipids (SLs), and recently, we reported that P. gingivalis SLs packaged into outer membrane vesicles (OMVs) can regulate THP-1 macrophage inflammatory responses to P. gingivalis OMVs. The contribution that P. gingivalis SLs have on host-pathogen interactions remains poorly understood, especially in the context of OMVs. Here, we demonstrate that P. gingivalis SLs significantly reduce the uptake of OMVs isolated from SL-containing wild-type (WT) P. gingivalis compared to OMVs from an SL-null mutant P. gingivalis strain, and that the loss of SLs drives uptake of P. gingivalis OMVs via lipid rafts in THP-1 macrophages. Intriguingly, we found that the sensing of P. gingivalis OMVs via TLR2 and MyD88 is attenuated due to the presence of SLs. Lastly, transcriptomic analysis of THP-1 macrophages co-cultured with either WT or SL-null P. gingivalis OMVs for 2 h revealed an array of differentially expressed genes. Interestingly, at 2 h, WT P. gingivalis OMVs promoted an overall trend of gene downregulation in THP-1 macrophages when compared to unchallenged, whereas SL-null OMVs strongly promoted upregulated gene expression. These findings provide early-phase characterization of the role of SLs in initial host cellular responses to P. gingivalis OMVs and expand our knowledge of interactions between SL-containing P. gingivalis OMVs and the host.
KEYWORDS: transcriptome, macrophage, innate immune sensing, host-pathogen interaction, outer membrane vesicles, sphingolipids, Porphyromonas gingivalis
INTRODUCTION
Sphingolipids (SLs) are a diverse class of membrane phospholipids composed of a sphingoid long-amino alcohol chain, fatty acid, and variable lipid head group (1). SLs are de novo synthesized by the enzyme serine palmitoyltransferase (SPT) that catalyzes the first step in the pathway. SL production is nearly ubiquitous among eukaryotes, and these lipids play important roles in multiple cellular processes such as stress response, cell signaling, and inflammation (1). Contrary to eukaryotes, SL synthesis is relatively uncommon among prokaryotes, with only approximately 100 bacterial phyla, including Proteobacteria, Chlorobi, and the Bacteroidota, known to synthesize SLs (2). Our functional understanding of the contributions of microbial SLs to bacteria is much less understood than their eukaryotic counterparts. Interestingly, work with the gut commensal Bacteroides thetaiotaomicron shows that the SLs of this organism are detected in intestinal tissues, and their presence in these tissues preserves intestinal health (3). Outside the gut, other sites, including the oral cavity, are known to harbor microbial SLs. Work by Nichols et al. (4) reported the identification of and shifts in microbial SLs present in gingival tissues of healthy individuals and those with periodontal disease, supporting that microbial SLs play an important role in periodontal disease progression.
Porphyromonas gingivalis is a gram-negative oral bacterium of the phylum Bacteroidota. This organism is closely associated with the highly prevalent chronic oral inflammatory disease known as periodontitis. Periodontitis affects approximately 47% of adults over the age of 30 (5) and is characterized by immune dysregulation driven by a polymicrobial dysbiosis of the subgingival biofilm. The resulting exacerbated host inflammatory response leads to irreversible destruction of the periodontal soft tissues and progressive alveolar bone resorption, ultimately contributing to tooth loss (6). Current therapy relies primarily on mechanical disruption of subgingival biofilm through scaling and root planing. Other adjuvant treatments can also be used, such as host immunomodulation therapies (7), offering additional potential benefits to limit tissue destruction. Nevertheless, these approaches are not sufficient to eradicate the disease. Although the precise mechanisms that initiate and sustain periodontitis remain unclear, the disease is recognized as a risk factor for diabetes mellitus and has also been associated with several systemic conditions, including rheumatoid arthritis, cardiovascular diseases, respiratory diseases, inflammatory bowel disease, among others (8). Interestingly, P. gingivalis or its products can translocate from the oral cavity to distant sites and have been detected in these extra-oral sites (6, 9–12). Similar to other members of the Bacteroidota phylum, P. gingivalis is capable of de novo SL biosynthesis (13–15). Employing purified SLs from P. gingivalis such as Lipid 1256 and Lipid 430 identified that these lipids can elevate inflammatory responses in host cells (16, 17), although how SLs contribute to the inflammatory response to P. gingivalis in the context of a live organism was unknown at that time. Following identification, an initial characterization of the SPT gene of P. gingivalis responsible for encoding the key enzyme required for SL biosynthesis, SPT (15), it was found using various immune cells that in the context of live organisms, P. gingivalis SLs limit host inflammatory responses to this organism (13, 18).
An interesting feature of P. gingivalis is its ability to package and secrete its virulence factors into nanosized spherical proteoliposomes known as outer membrane vesicles (OMVs) (19). P. gingivalis OMVs are loaded with internal and external cargo elements such as novel lipids (amino lipids and SLs), lipopolysaccharide (LPS), outer membrane and periplasmic proteins, and nucleic acids (20). Interestingly, it has been shown that there is both diversity among P. gingivalis OMVs in both size and cargo (21, 22). Although we do not fully understand all the benefits OMVs provide to P. gingivalis, it is known that OMV production by other bacteria is involved in several key processes, including nutrient acquisition, stress response, and cellular communication between host cells and other microbes (19, 23, 24). Recently, our group extended our understanding of P. gingivalis OMVs by identifying these structures as a delivery platform that P. gingivalis utilizes to transfer its own SLs to host cells, therefore limiting the host inflammatory responses to these OMVs. This process is similar to what was found to happen with whole organisms, thus supporting that SLs or the SL-associated cargo of P. gingivalis OMVs functionally regulate host inflammation (25), although precisely how P. gingivalis OMVs interact with the host is unclear.
Sensing of P. gingivalis OMVs by host cells involves Toll-like receptors (TLRs), especially TLR2 and TLR4 (26). These findings are consistent with results from in vitro live P. gingivalis bacterial challenge studies and animal modeling implicating the importance of TLR2 and TLR4 in the sensing of this organism (27–31). Beyond sensing, the uptake of P. gingivalis OMVs by host cells has primarily been studied using cells of epithelial origin, and to date, the mechanism of uptake of P. gingivalis OMVs appears to be cell nuanced, as several mechanisms have been described. For example, P. gingivalis OMV uptake appears to occur in a caveolin-mediated lipid raft endocytic process by HeLa cells (32), while a lipid raft-dependent endocytic pathway independent of caveolin was reported using human gingival epithelial cells (33), and when employing SY5Y human neuroblastoma and BV-2 mouse microglial cells, uptake of P. gingivalis OMVs was found to involve clathrin-dependent endocytosis (34). Macrophages have been shown to play a key role in sensing P. gingivalis (35) and are required for P. gingivalis to drive oral bone loss (36). However, there is limited information on bacterial OMV uptake via macrophages, and it is not understood how P. gingivalis OMVs are taken up by these cells and the impact of P. gingivalis SLs on the uptake of P. gingivalis OMVs.
Herein, we report that during the early events of the host response, P. gingivalis SLs incorporated in OMVs reduce OMV uptake by THP-1 macrophages. We also report that the absence of P. gingivalis SLs promotes strong lipid-raft-dependent endocytosis of OMVs via THP-1 macrophages. Furthermore, we found that immune sensing of P. gingivalis OMVs occurs via the TLR2 and myeloid differentiation primary response 88 (MyD88) axis. Lastly, transcriptomics of THP-1 cells co-cultured with wild-type (WT) OMVs for 2 h identified suppressed gene and pathway expression, while SL-null OMVs activated gene and pathway expression. Overall, our findings identify novel contributions of SLs to the interaction between P. gingivalis and the host via OMVs.
RESULTS
Lipophilic dye labeling does not affect P. gingivalis OMV size, composition, and elicited inflammation
We found, using nanoparticle tracking analysis (NTA), that our isolated and purified OMVs from SL-containing WT P. gingivalis and P. gingivalis SPT mutant (SL-null) strains displayed physical characteristics similar to what we previously reported (25). As multiple studies have used lipophilic dye staining to monitor bacterial OMV uptake and trafficking by fluorescent microscopy (37–39), we first characterized the impact of DiO labeling on P. gingivalis OMVs, as prior reports suggest that lipophilic dye labeling can impact the biological activity of OMVs (40, 41). Using NTA, we found the average OMV size and distribution did not change between WT and SL-null OMVs due to the labeling process (Fig. 1A through D). We confirmed via negative stain-transmission electron microscopy (TEM) that unlabeled WT and SL-null OMVs have similar morphology (Fig. 1E and G). In addition, we found that the OMV membrane appeared intact after labeling and resembled unlabeled OMVs for both WT and SL-null OMVs (Fig. 1E through H). To understand if labeling of OMVs caused functional changes in the way host cells responded to labeled OMVs, we cultured THP-1 macrophages with unlabeled and labeled P. gingivalis OMVs and performed multiplex immunoassays on the culture supernatant fluids. When comparing the cytokine and chemokine profiles of THP-1 macrophages cultured with unlabeled and DiO-labeled P. gingivalis OMVs, DiO labeling had a minor impact on SL-null OMV cytokine or chemokine activity (P > 0.05 for all), as well as for WT P. gingivalis OMVs (P > 0.05), with the exception of a modest change in TNF-α (P < 0.05) (Fig. S1). Taken together, these data support that DiO labeling did not alter P. gingivalis W83 WT or SL-null OMVs and supported their use in OMV uptake assays.
Fig 1.

Characterization of P. gingivalis OMVs using NTA and negative-stain TEM. 1 × 1011 P. gingivalis W83 WT (A and B) and SL-null (ΔSPT; C and D) OMVs were either unlabeled (A and C) or labeled with DiO lipophilic dye (B and D) and analyzed by NTA to characterize OMV size (x-axis) and relative concentration (y-axis). Negative staining TEM was performed to assess ultrastructure of the corresponding OMV samples before (E and G) and after (F and H) DiO labeling; scale bar = 200 nm.
P. gingivalis sphingolipids limit OMV uptake by THP-1 macrophages
Several studies have found that bacterial OMVs can have a profound effect on host cellular responses (i.e., proliferation and inflammation) (42–44). Yet despite these findings, there is a gap in knowledge on how OMVs are initially taken up by macrophages. The uptake of OMVs is known to be impacted by the various cargo elements that make up its composition, such as outer membrane proteins, bacterial toxins, peptidoglycan, nucleic acids such as siRNA and DNA, and bacterial lipids such as LPS (45). To understand the effect SLs have on P. gingivalis OMV uptake, we challenged THP-1 cells with DiO-labeled P. gingivalis WT and SL-null OMVs and measured OMV uptake by confocal fluorescence microscopy. We observed that there was significantly more uptake of SL-null OMVs (mean = 54,432 ± 15,437 µm2) compared to WT OMVs (mean = 15,635 ± 5,170 µm2) (P < 0.05; Fig. 2A and B). These data support that P. gingivalis SLs limit OMV uptake by THP-1 macrophages.
Fig 2.

P. gingivalis OMV uptake by THP-1 macrophages is reduced by SLs. (A) Top to bottom: THP-1 macrophages were either untreated or challenged with DiO-labeled P. gingivalis W83 WT (WT) or SL-null (ΔSPT) OMVs at 1,000 OMVs/cell for 2 h. 3-D Z-stack images of representative fields were taken at 600× magnification and converted to 2-D HDR images. Left to right: merged, DAPI only (nuclei; blue), DiO only (OMVs; green), and CellTracker Red only (membrane; red), scale bar = 25 µm. Merged images for each condition show XZ (bottom panel) and YZ (right side panel) orthogonal views. (B) Regions of interest (ROIs) were traced around the perimeter of 250 individual cells, and the sum area of internalized OMVs (green; µm2) of each ROI was measured. Bars represent mean ± SEM values, n = 5 independent experiments. Data were analyzed by unpaired t-test and * = P < 0.05.
Sphingolipid status impacts OMV uptake via lipid rafts
Previous studies investigating WT P. gingivalis OMV uptake have found that lipid rafts played a role in that process (32–34). Furthermore, these studies have primarily focused on epithelial cells (32, 33). Currently, it is not known how phagocytic cells such as macrophages take up P. gingivalis OMVs, and what the contribution SLs have on this uptake mechanism. Using methyl-β-cyclodextrin (MβCD) to disrupt THP-1 cell lipid rafts before OMV challenge, we first optimized the concentration of MβCD needed to sequester cholesterol from the THP-1 cell membrane and found that 10 mM MβCD maximally depleted cholesterol without impacting THP-1 cell viability (Fig. S2 and S3). Employing this condition, we found that MβCD treatment of THP-1 macrophages did not significantly reduce WT P. gingivalis OMV uptake compared to cells that did not receive MβCD treatment (P = 0.8873, Fig. 3). Interestingly, we observed MβCD treatment profoundly reduced THP-1 cell uptake of SL-null OMVs (P < 0.05, Fig. 3). These data support that while P. gingivalis WT OMVs are not taken up by a mechanism that involves lipid rafts, SL-null OMV uptake clearly involved lipid rafts, thus the bacterial SLs play an important role in the way THP-1 macrophages take up P. gingivalis OMVs. As the route of OMV uptake is known to impact elicited inflammatory responses from challenged host cells (46, 47), we also investigated the effect of lipid raft disruption on P. gingivalis OMV-elicited inflammation after MβCD inhibition. Regardless of the cytokines and chemokines examined, there were no significant differences found between inhibitor-treated or untreated THP-1 cells in their response to WT or SL-null OMVs (Fig. S4). These data support that WT P. gingivalis OMV-elicited inflammation occurs independently of lipid rafts in THP-1 macrophages.
Fig 3.

Uptake of P. gingivalis SL-null OMVs is dependent upon lipid rafts. (A) Top to bottom: THP-1 macrophages were either untreated or treated with the cholesterol sequestration agent MβCD (10 mM) to disrupt lipid rafts and were then challenged with DiO-labeled WT P. gingivalis OMVs (WT) or SL-null OMVs (ΔSPT) at 1,000 OMVs/cell for 2 h. 3-D Z-stack images of representative fields were taken at 600× magnification and converted to 2-D HDR images. Left to right are merged, DAPI only (nuclei; blue), DiO only (OMVs; green), and CellTracker Red only (membrane; red), scale bar = 25 µm. (B) ROIs were traced around the perimeter of 250 individual cells, and the sum area of internalized OMVs (green; µm2) of each ROI was measured. Bars represent mean ± SEM values, n = 5 independent experiments. Data were analyzed by unpaired t-test; ns, not significant; * = P < 0.05.
SLs alter TLR- and MyD88-dependent innate immune sensing of P. gingivalis OMVs
As it is known that P. gingivalis OMVs can activate cells in both a TLR2- and TLR4-dependent manner (26), we cultured HEK-Blue hTLR2 and hTLR4 reporter cells with WT and SL-null OMVs to investigate the contribution of SLs to innate immune sensing of P. gingivalis OMVs via TLRs. As expected, our positive controls, Pam2CSK4 (Pam2; TLR2) and ultra-pure Escherichia coli LPS (TLR4), were specific (Fig. 4). Interestingly, SL-null OMVs elicited a much stronger signaling phenotype than was observed with WT OMVs (Fig. 4A). Employing TLR4 reporter cells, we observed that there were no significant differences between OMV treatments (P > 0.05, Fig. 4B).
Fig 4.

The SLs of P. gingivalis influence TLR sensing of its OMVs. HEK-Blue cells: hTLR2 (A) and hTLR4 (B), as well as THP-1 Dual cells: CTRL (C), TRIF-KO (D), and MyD88-KO (E) cells were challenged with P. gingivalis W83 OMVs from WT or SL-null (ΔSPT) at 1,000 OMVs/cell. Pam2CSK4 (Pam2) served as TLR2 positive control for HEK-Blue cells and as a control for MyD88-dependent THP-1 Dual cells. UltraPure E. coli LPS (LPS) served as TLR4 positive control. Recombinant TNF-α served as a MyD88-independent positive control. Vehicle alone (V)-treated cells served as a baseline. SEAP levels were measured spectrophotometrically at 620 nm. Bars represent mean ± SEM values, n = 3–5 independent experiments. Data were analyzed by unpaired t-test; ns, not significant; * = P < 0.05.
To further investigate the impact of SLs on TLR signaling, we utilized control THP-1 reporter cells as well as their TRIF-KO and MYD88-KO mutant cell lines to understand the importance of these adaptor molecules in the sensing of WT and SL-null OMVs. We found that control reporter cells possessing both MyD88 and TRIF responded less robustly to P. gingivalis WT OMVs compared to SL-null OMVs (Fig. 4C). Using TRIF-KO cells (MyD88-signaling intact), we found that there was a similar response profile to that observed with control reporter cells for WT and SL-null OMVs (Fig. 4D). Interestingly, when using the MYD88-KO cell line (TRIF-signaling intact), we found OMVs from both strains were only minimally sensed (Fig. 4E), thus supporting that MyD88 is a key signaling pathway adaptor molecule for TLR sensing of P. gingivalis OMVs.
Transcriptomic analysis of THP-1 macrophages co-cultured with OMVs
To understand the contribution of P. gingivalis OMV SLs in the host-pathogen interaction, we analyzed the transcriptome of THP-1 macrophages cultured with WT OMVs or SL-null OMVs for 2 h, and medium-only treatment served as control. Heatmap analysis showed striking differences between the treatments, while gene expression patterns of the biological replicates within each group were highly similar (Fig. S5). Both WT OMVs and SL-null OMVs elicited transcriptomic shifts in THP-1 macrophages versus THP-1 macrophages cultured in medium alone. Examining the data to identify differentially expressed genes (DEGs) elicited by P. gingivalis OMVs, we found 95 DEGs (37 upregulated and 58 downregulated) when comparing THP-1 macrophages co-cultured with WT P. gingivalis OMVs to cells cultured in medium alone (Fig. 5). When comparing SL-null OMV treatment to the untreated control, we found 260 DEGs (209 upregulated and 51 downregulated) (Fig. S6). Lastly, comparing SL-null OMVs challenge to WT OMVs, we observed 320 total DEGs (281 upregulated and 39 downregulated) (Fig. 6). The lists of all DEGs can be found in the supplementary materials (Table S1 to S6).
Fig 5.

Volcano plot illustrating the transcriptome of THP-1 macrophages co-cultured with WT OMVs versus untreated THP-1 cells (CTRL). Differential expression analyses were performed with cutoffs for log2-fold change >1.0 and P-value <0.05. Upregulated genes are red and downregulated genes are blue.
Fig 6.

Volcano plot illustrating the transcriptome of THP-1 macrophages co-cultured with SL-null OMVs (SPT) versus THP-1 cells co-cultured with WT OMVs. Differential expression analyses were performed with cutoffs for log2-fold change >1.0 and P-value <0.05. Upregulated genes are red and downregulated genes are blue.
Among the DEGs found between THP-1 macrophages cultured with WT P. gingivalis OMVs compared with unchallenged cells, we unexpectedly observed more genes downregulated (61%) than upregulated (39%). Top downregulated genes include IL1A, EXOC3L4, POLN, CCL8, DNLZ, and PIK3R6, while top upregulated genes included CLMN, CNTNAP2, GABRB2, FBXO16, AURKC, CELF3, GBP1, and TFAP2C (Fig. 5, Table S4). Interestingly, when comparing THP-1 macrophages co-cultured with SL-null OMVs to THP-1 macrophages co-cultured with WT OMVs, we found 88% upregulated genes and 12% downregulated, with the top upregulated genes including EGR3, CXCL3, IL1A, TNFAIP6, CXCL2, and CXCL1, and the top downregulated genes including IGFLR1, ARHGAP40, CELF3, and TJP3 (Fig. 6). Finally, comparing SL-null OMV treatment to medium-only, we observed 80% of genes upregulated, including LAMP3, IL18AP, IL6, and CXCL3, while 20% were downregulated and included JAML, RASRF2, and NHLRC1 (Fig. S6).
Pathways and gene ontology affected
To obtain a higher-order understanding of the gene expression profiles, we performed KEGG pathway analysis. At 2 h, when comparing WT to untreated cells, we found 12 enriched pathways that were differentially expressed. We found only 1 pathway activated (but not significant; P > 0.05), and similar to what was observed at the gene expression level, 11 pathways were found suppressed, with 7 being significantly different (P < 0.05). All those significantly suppressed genes relate to elements of host inflammatory responses including “cytokine-cytokine receptor interaction,” “chemokine signaling pathway,” “IL-17 signaling pathway,” and “TNF signaling pathway” (Fig. 7A). KEGG analysis of THP-1 macrophages cultured with SL-null OMVs versus WT OMVs revealed that 15 pathways were activated (P < 0.05 for all comparisons), including “viral protein interaction with chemokine and cytokine receptor,” “cytokine-cytokine receptor interaction,” “TNF signaling pathway,” “NF-kappa B signaling pathway,” “IL-17 signaling pathway,” “c-type lectin receptor signaling pathway,” and “Toll-like receptor signaling pathway,” while only three pathways were found mildly suppressed (not significant; P > 0.05) (Fig. 7B). Notably, when we compared the top up- and downregulated DEGs from the WT OMVs vs untreated THP-1 macrophages to the top activated or suppressed enriched KEGG pathways, we found that some downregulated genes were linked to “cytokine-cytokine receptor interaction” (IL1A, CCL8) and “chemokine signaling pathway” (CCL8, PIK3R6). We found that all of these pathways were suppressed in response to P. gingivalis OMVs (Fig. 7A and Table S7).
Fig 7.

Enrichment pathway analysis of DEGs in THP-1 macrophages co-cultured with P. gingivalis OMVs. (A) THP-1 macrophages co-cultured with WT OMVs versus untreated (CTRL), (B) THP-1 macrophages co-cultured with SL-null (∆SPT) OMVs versus co-cultured with WT OMVs, (C) THP-1 macrophages co-cultured with ∆SPT OMVs versus CTRL. KEGG pathways are grouped into suppressed pathways (left) and activated pathways (right). The GeneRatio on the x-axis indicates the proportion of genes involved in each pathway. Circle size reflects the gene count associated with each pathway, and circle color represents the adjusted P-value (p.adjust), from red (significant), purple to blue (not significant).
The transcription profile of top upregulated genes from the SL-null OMVs to WT OMVs challenge aligned with KEGG pathways: “Toll-like receptor signaling” (CCL8), “c-type lectin receptor signaling” (EGR3), “TNF signaling” (CXCL2, CXCL3, IL18R1), “IL-17 signaling pathway” (IL17C), “cytokine-cytokine receptor interaction” (IL1A, CCL8), and “NF-kappa B signaling pathway” (NFKB1, CXCL1). Fascinatingly, these pathways were significantly activated (Fig. 7B and Table S8), further supporting that SLs are strongly tied to the early immune response to P. gingivalis OMVs. The transcription profile comparing SL-null OMV-challenged THP-1 cells vs untreated THP-1 cells showed a similar transcriptional profile and the same activated KEGG pathways mentioned previously in our SL-null vs WT OMVs group (Fig. 7C and Table S9). Ultimately, these findings of the transcriptional landscape in the absence of SLs in P. gingivalis OMVs lead to an accentuated inflammatory response in host cells, supporting that P. gingivalis SLs dampen the host response in several areas related to host cellular response.
DISCUSSION
The importance of microbial SLs in periodontal disease has been established (4, 48), but precisely how these lipids impact periodontal disease pathogenesis remains unclear. Although SL production by bacteria is rare, early work in this area focused on structural characterization of P. gingivalis SLs and characterization of host response to these lipids in pure form when cultured with host cells (14, 49–54). A seminal study by Moye et al. (15) identified the P. gingivalis gene responsible for encoding SPT, the key enzyme for SL de novo biosynthesis, which allowed for study of P. gingivalis SLs in the context of live bacteria. Employing this mutant, our group had recently shown that SLs limit the host immune response to P. gingivalis, as live WT P. gingivalis elicited a significantly lower inflammatory response from macrophages compared to the SL-null mutant, which was also found to be recapitulated using only purified OMVs from these strains (13, 25). In our present study, we determined that the uptake of P. gingivalis OMVs by macrophages is significantly impacted by SLs, as P. gingivalis WT OMVs were taken up significantly less than OMVs from the SL-null mutant. We also found that for P. gingivalis WT OMVs, the uptake mechanism by these cells appears to be independent of lipid rafts. While WT OMV uptake was not impacted by lipid raft disruption, we found that P. gingivalis SL-null OMVs revealed a strong association with lipid raft-mediated uptake. Innate immune sensing of both WT and SL-null P. gingivalis OMVs was dependent on TLR2/MyD88 signaling, but not via TLR4 or TRIF. Lastly, using a global transcriptional approach, we observed profound differences in the transcriptional profiles of macrophages cultured with WT OMVs compared with OMVs from the SL-null mutant and revealed that very early in OMV-host cell interactions, SLs appear to play an important role in limiting the early-phase activation of these immune cells to P. gingivalis OMVs.
To the best of our knowledge, our present study is the first detailed investigation to characterize the early host interaction and global transcriptional response to P. gingivalis OMVs and is the first study to begin to define the impact microbial SLs have on OMV binding and uptake. Interestingly, employing macrophage modeling and comparing P. gingivalis OMV uptake to other bacteria linked to periodontal diseases, including Treponema denticola and Tannerella forsythia, it was reported that P. gingivalis OMVs bound to macrophages more readily than the OMVs of the other organisms. P. gingivalis OMVs are more potent activators of NF-κB, yet elicited a less robust inflammatory cytokine response from these cells than the other periodontal disease-associated bacterial OMVs (26, 55), suggesting that there may be some level of control of the host response to P. gingivalis OMVs, which is intrinsic to these structures. Our current findings align with these prior reports in that P. gingivalis WT OMVs are taken up readily by macrophages (Fig. 2). Importantly, we observed that the increase in P. gingivalis OMV uptake depended on the OMV molecular cargo, as the SL-null OMV uptake was significantly more robust than observed with WT OMVs, implicating that P. gingivalis SLs play a major role in P. gingivalis OMV uptake by macrophages.
The concept that OMV cargo impacts uptake and function of these structures is relatively new, and likely is nuanced between bacteria. For example, and similar to what we observed examining SLs, it was reported that E. coli OMV uptake is impacted by its LPS O-antigen cargo, as the LPS O-antigen mutant OMVs were more readily taken up than WT OMVs (56). Although our data support that the SLs are the cargo element responsible for this shift in P. gingivalis OMV uptake, we cannot rule out other cargo elements in the OMVs from SL-null P. gingivalis, as we previously reported that, in comparison to WT OMVs, the OMVs from SL-null P. gingivalis have different arrays of protein cargo (25). Regardless, when taken together, it is clear that shifts in bacterial OMV cargo and the cells these structures interact with have important biological implications in host-pathogen interaction.
Studies have investigated uptake and function of bacterial OMVs using various host cells and have revealed important knowledge as to how bacterial OMVs impact host interaction. Importantly, we reported that P. gingivalis SLs are delivered to host cells in an OMV-dependent manner, and that the transfer of these SLs influenced the host cytokine and chemokine response to P. gingivalis OMVs (25). Our studies now extend from prior work on the mechanism of P. gingivalis OMV uptake (32, 33), and support that there are cell-specific nuances in how P. gingivalis OMVs are taken up. In our hands, macrophages do not appear to take up WT P. gingivalis OMVs using solely a lipid raft system. Similar studies using SY5Y neuroblastoma and BV-2 microglial cells, reported that WT P. gingivalis OMVs were internalized via clathrin-dependent endocytosis (34). Our findings revealed that shifts in OMV SL cargo had a profound influence on OMV uptake. The concept that OMV cargo impacts OMV uptake was established with Helicobacter pylori where VacA cytotoxin containing OMVs shift toward clathrin-dependent endocytosis while VacA mutant OMVs favored clathrin-independent uptake (37). Further studies are needed to fully characterize the cell-specific mechanisms of P. gingivalis OMV uptake.
It is known that TLRs play an important role in host sensing of P. gingivalis and its antigens (27, 57, 58). Indeed, TLR2 and MyD88 are linked to numerous functional endpoints of host-pathogen interaction, including oral bone loss (27, 29, 59–61). Previously, we reported that P. gingivalis SLs impact TLR and TLR adaptor molecule gene expression; however, these studies did not address whether these SLs impact TLR sensing of its OMVs (25). Employing TLR receptor and TLR adaptor molecule reporter cell assays, we found there was a significant increase in TLR2 sensing of SL-null OMVs compared to WT OMVs (Fig. 4A). In addition, there were no significant differences observed in OMVs from both strains by TLR4 reporter cells (Fig. 4B). To understand the mechanisms of TLR signaling, we used TLR adaptor molecule reporter cell lines and found that the vast majority of P. gingivalis OMV signaling, either WT or SL-null, went through MyD88, but not TRIF (Fig. 4C through E). This aligns with knowledge that TLR2 signaling is MyD88-restricted (62). To the best of our knowledge, these are the first reports directly examining the adaptor molecule involvement in TLR sensing of P. gingivalis OMVs. Prior studies show that OMVs from P. gingivalis 33277 and strain W50 are sensed by both TLR2 and TLR4 (26, 57, 63). We do not know why our OMVs were not sensed by TLR4; however, this may reflect nuanced differences between P. gingivalis strains used (64, 65). Understanding why OMVs from different P. gingivalis strains trigger distinct TLR responses is needed, and targeted follow-up studies are needed to elucidate the underlying mechanisms. Our approach to isolate OMVs utilized culture conditions that more resemble the host environment (RPMI-1640 medium supplemented with fetal bovine serum [FBS]) compared to traditional P. gingivalis media conditions (26). It is possible that under these conditions, OMV cargo changes could lead to differences in TLR responses. Interestingly, it has also been shown that P. gingivalis Lipid A structure can affect TLR4 sensing of P. gingivalis OMVs (63). Furthermore, P. gingivalis can modify its Lipid A structure in response to environmental change, such as hemin availability and temperature (48). Although the significance of Lipid A structure in our RPMI-derived OMVs in the context of SL status is currently unknown, future studies should be performed to determine the impact of different environmental growth conditions on P. gingivalis OMV cargo and downstream host TLR interaction.
Host interaction with bacterial vesicles has primarily focused on defining mechanisms of vesicle uptake, host sensing, cellular toxicity, and, in some cases, functional outcomes such as cytokine and chemokine expression (26, 34, 45, 66). Yet, few studies have investigated the very early global cellular response to bacterial OMV exposure (67). To the best of our knowledge, the present study is the first investigation to define the impact of bacterial lipid OMV cargo on the early-stage global cellular response of the host to OMVs. When we analyzed the early transcription response of THP-1 cells stimulated with WT P. gingivalis OMVs, we unexpectedly observed a predominance of downregulated genes compared to unstimulated controls. Pathway analysis reinforced this pattern. These downregulated pathways included key immunomodulation mechanisms such as “cytokine-cytokine receptor interaction,” “chemokine signaling,” and “TNF signaling pathway.” Conversely, THP-1 cells stimulated with SL-null OMVs showed a profile characterized by a stronger percentage of upregulated gene expression than downregulation observed with WT OMVs, highlighting a contribution of SLs found in P. gingivalis OMVs to the host response. Investigating this further at the level of pathway enrichment, this trend was further supported as most differentially expressed pathways between SL-null OMV and WT OMV challenged THP-1 cells were upregulated, and interestingly, we observed a correlation between our transcriptional data and cytokine levels for IL-1β and IL-6, as these genes were upregulated (Fig. 6), and protein secretion at higher levels by the SL-null mutant compared to WT (Fig. S1). Little is known about the transcriptional changes between host cells exposed to live P. gingivalis and OMVs. However, work by Castillo et al. (68), using live bacteria, shows cell exposure to WT P. gingivalis shifted cellular gene expression into a more activated state than what they found with OMVs. In a proteomics approach-based study, it was found that P. gingivalis challenged human gingival epithelial cells presented with a mixed array of upregulated and downregulated proteins being expressed, yet similar to our gene transcription findings, more proteins were at lower levels than were found increased; however, this study reported protein content at 6 h and not at 2 h (69). Although we do not understand why WT P. gingivalis OMVs drove suppression of gene expression in the early phase of host response, it has been reported by our group that WT P. gingivalis W83 bacteria and its OMVs were less inflammatory to THP-1 cells compared with SL-null OMVs (25). This observation of reduced inflammation is broadly aligned with studies of Brown et al. (3), who reported that WT B. thetaiotaomicron elicited significantly less inflammation than an SL-null B. thetaiotaomicron strain in the context of an inflammatory bowel disease mouse model.
P. gingivalis SL-null OMVs elicited enrichment of multiple pathways linked to inflammatory disease, including “Rheumatoid Arthritis” and “Inflammatory Bowel Disease.” The overlap is notable, as periodontitis and rheumatoid arthritis share a similar overexpression of TNF-α, IL-1, and IL-6 (70), and IL-1A overexpression has been reported in rheumatoid arthritis patients (69). Moreover, rheumatoid arthritis targeted biologics, such as IL-6R inhibitors, have been observed to improve periodontitis in rheumatoid arthritis patients (71). This suggests that disrupted cytokine networks may form a mechanistic bridge between these two inflammatory conditions. The enrichment of inflammatory bowel disease pathways in the absence of SLs is equally intriguing, given that several of our top upregulated inflammatory genes (including IL6 and IL18RAP) are implicated in inflammatory bowel disease pathogenesis.
In addition to the array of upregulated THP-1 pathways related to inflammation/host response to infection pathways elicited by SL-null OMVs, we also found an opposite effect on pathways related to carbohydrate metabolism, including “ascorbate and aldarate metabolism,” “fructose and mannose metabolism,” and “glycolysis/gluconeogenesis,” which were suppressed, as were “cholesterol metabolism” in the SL null OMV-treated THP-1 cells compared to WT OMV-treated cells. It is currently unknown why the absence of SLs leads to a suppression of host metabolic pathways. Future studies into how bacterial SLs expression alters host metabolism are needed to functionally understand these connections. Intriguingly, it has been shown that Bacteroides SLs can be incorporated into host metabolic pathways (2, 3, 72), and that metabolic shifts can occur in host cells in response to different TLR stimuli to meet the nutritional needs of the responding cell (73, 74). When our findings are taken with those of previous studies (2, 3, 72), an intriguing picture is emerging that bacterial SLs may support and possibly maintain host homeostasis and could be part of an interkingdom communication program between specific microbes and the host.
In conclusion, this study advances our understanding of early host-pathogen interactions by demonstrating that P. gingivalis SLs critically shape OMV uptake and the resulting host transcriptional response. These findings provide new mechanistic insight into how OMV cargo influences immune recognition. The exact mechanisms behind this SL-mediated suppressive effect, however, remain unrevealed. Future investigations are essential to delineate how P. gingivalis, its sphingolipids, and their OMVs collectively modulate host immune responses.
MATERIALS AND METHODS
Bacterial growth
P. gingivalis WT strain W83 and its SL-null (∆SPT) mutant (15) were grown anaerobically at 37°C for 3–5 days on Trypticase Soy Broth Blood Agar plates supplemented with 5 µg/mL hemin and 1 µg/mL menadione (TSB-BAPHK), and were then transferred to similarly supplemented Trypticase Soy Broth (TSBHK), and bacteria were cultured for approximately 18 h to the late log phase, where they were subsequently used for generating OMVs.
OMV purification and isolation
P. gingivalis WT and SL-null OMVs were isolated and purified as previously described (25). Briefly, bacteria grown in TSBHK were transferred to RPMI-1640 with 10% heat-inactivated FBS, incubated anaerobically for 24 h, then aerobically for 6 h. OMV-containing supernatants were clarified by centrifugation and 0.2 µm filtration, concentrated by ultrafiltration, and pelleted by ultracentrifugation. Pellets were purified via OptiPrep density-gradient centrifugation, repelleted, resuspended in PBS, and characterized by NTA and electron microscopy before use in experiments.
Nanoparticle tracking, negative stain-TEM, and fluorescent labeling of P. gingivalis OMVs
The concentration and size distribution of the P. gingivalis WT and SL-null OMV preparations was determined by NTA using Nanosight NS300 (Malvern Panalytical, Malvern, UK), which is part of the UF Interdisciplinary Center for Biotechnology Research (UF ICBR) collection of core equipment. The morphology of purified OMVs was determined by negative stain-TEM. To accomplish this, a 5 μl volume of OMV suspensions (WT and SL-null) was applied to formvar-coated copper grids, stained with 2% uranyl acetate for 30 s, and analyzed using a 120 kV Tecnai G2 Spirit TWIN transmission electron microscope.
To fluorescently label P. gingivalis OMVs, we adapted the method of Jones et al. (39), where we incubated OMVs with Vybrant DiO lipophilic dye (Thermo Fisher Scientific, Waltham, MA) following the manufacturer’s instructions. Briefly, 1 × 1011 P. gingivalis W83 WT and SL-null OMVs/mL were incubated with Vybrant DiO lipophilic dye at 37°C for 30 min, washed with PBS coupled with ultracentrifugation at 100,000 × g at 4°C to remove unincorporated DiO dye, and the labeled OMVs were resuspended in PBS and stored at 4°C for a maximum of 1 month. NTA and negative stain-TEM were used to assess both unlabeled and labeled OMVs, as indicated above. In some experiments, unlabeled and DiO-labeled OMVs were added to THP-1 cells to determine if DiO labeling impacted the elicited THP-1 cytokine/chemokine response (quality control). Culture supernatant fluids were collected and stored frozen at −80°C for multiplex immunoassays. In OMV uptake experiments, DiO-labeled OMVs (1,000 OMVs/cell) were added to THP-1 cells to visualize and quantify uptake via confocal fluorescence microscopy.
THP-1 cell culture
THP-1 cells, a human monocyte-like cell line (TIB-202, ATCC, Manassas, VA), were cultured in RPMI-1640 media containing 2 mM L-glutamine (Corning, NY), supplemented with 10% heat-inactivated FBS, 10 mM HEPES, 25 mM glucose, 1 mM sodium pyruvate, 18 mM sodium bicarbonate, 55 μM β-mercaptoethanol, and 100 μg/mL antibiotics (penicillin and streptomycin; P/S) at 37°C in a 5% CO2 incubator, and were differentiated into a macrophage-like state in complete RPMI-1640 media containing 100 ng/mL phorbol-12-myristate-13-acetate (PMA; Sigma-Aldrich, St. Louis, MO), and 1 mL was added to wells of 24-well plates and incubated for 48 h (25). Following differentiation, THP-1 cells were washed, fresh complete media was added to each well, and these cells were used in experiments outlined below.
P. gingivalis OMV uptake assays
For OMV uptake experiments, THP-1 cells were cultured on sterile standard glass coverslips, either untreated or challenged with WT and SL-null DiO-labeled P. gingivalis OMVs (1,000 OMVs/cell) for 2 h. Glass coverslips were retrieved and incubated at room temperature for 1 min with 0.025% Trypan Blue solution (Corning, NY) in PBS to quench the fluorescence of non-internalized DiO-labeled OMVs (39). Next, coverslips were incubated with 18 µM CellTracker Red CMTPX dye (Thermo Fisher Scientific) in RPMI-1640 for 15 min at 37°C to label cell membranes. Cells were then fixed on the coverslips with 4% paraformaldehyde, and after washing, coverslips were mounted to microscope slides using DAPI-Fluoromount G mounting medium (Southern Biotech). OMV uptake was measured using confocal fluorescence microscopy; we first established the background fluorescence from THP-1 cells treated with medium alone. 3-D Z-stack images from representative fields were taken with 60× objective using a Nikon Ti2 confocal fluorescence microscope (Melville, NY), then converted to 2-D high dynamic range images for analysis with NIS Elements software (Melville, NY). For fluorescence quantification of OMV uptake (DiO/green channel), images from a minimum of 10 representative fields per sample were digitally captured, and then we traced the perimeter of cells to define the representative ROIs. This provided a direct measure of fluorescence associated with each cell. Lastly, we applied a binary mask to include only the DiO/OMV fluorescence channel in our analysis. The sum of the OMV fluorescence area (µm2) of each ROI was measured, and the total fluorescence area across all ROIs was calculated for 250 total THP-1 cells.
For OMV uptake inhibition studies, differentiated THP-1 cells were untreated or treated with 10 mM MβCD (inhibitor of lipid rafts) in RPMI-1640 media without supplements or cultured in medium alone for 30 min (32). MβCD treatment was then removed; THP-1 cells were then challenged with DiO-labeled WT or SL-null OMVs (1,000 OMVs/cell) in complete RPMI media without antibiotics as described above; microscope slides were also prepared as above.
Host cell cytokine/chemokine profiling
THP-1 cell culture supernatant fluids were thawed, and levels of TNF-α, IL-1β, IL-6, IL-10, IL-8, and RANTES were determined using 6-plex Human Luminex Discovery Assays (Biotechne, Minneapolis, MN). Data were acquired using MAGPIX Luminex system running xPONENT 3.1 software (Luminex, Austin, TX). Data were analyzed using a five-parameter logistic spline curve-fitting method via Milliplex Analyst V5.1 software (Vigene Tech, Carlisle, MA). Nonlabeled WT vs DiO-labeled WT and nonlabeled SL-null vs DiO-labeled SL-null OMV challenge data represent five biological replicates.
TLR- and TLR-signaling NF-κB reporter cells
HEK-Blue hTLR2 and hTLR4 cells were used to assess TLR sensing of P. gingivalis OMVs, while THP-1 Dual parental cell line (CTRL), TRIF-KO, and MyD88-KO NF-κB reporter cells were used to examine downstream TLR signaling. All cell lines were purchased from Invivogen (San Diego, CA) and handled following the manufacturer’s protocols (Invivogen). Frozen stocks of each cell line were stored in liquid nitrogen, and cultures were discarded before reaching 20 passages.
Reporter cell assays
HEK-Blue TLR2 and TLR4 reporter cells and all THP-1 Dual cells: parental THP-1 Dual or control (CTRL), TRIF-KO, and MyD88-KO cells were challenged with unlabeled WT and SL-null OMVs at 1,000 OMVs/cell (25) for 22 h (26). Positive controls for TLR2 and TLR4 sensing included 10 ng/mL Pam2CSK4 (TLR2 agonist) and 100 µg/mL Ultrapure E. coli LPS (TLR4 agonist) (Invivogen), while positive controls for MyD88-dependent and MyD88-independent sensing included 10 ng/mL Pam2CSK4 (MyD88-dependent agonist) and 1 ng/mL recombinant TNF-α (MyD88-independent agonist) (Invivogen), respectively. Baseline response levels for each cell line were established using the unchallenged controls cultured in detection medium with an equal volume of vehicle (endotoxin-free water). Following WT and SL-null OMV challenge, SEAP levels in reporter cell supernatants were measured via absorbance at 620 nm using H1 Synergy plate reader (Agilent Technologies, Santa Clara, CA). Background absorbance was subtracted from the supernatant fluids of cells treated with detection medium alone. Recombinant SEAP protein (0.1 ng/mL–100 ng/mL) (Invivogen, San Diego, CA) in detection medium was used to generate a standard curve for SEAP quantification.
THP-1 mRNA isolation and transcriptomic analysis
For transcriptomics assays, PMA-differentiated THP-1 cells were cultured as above for 2 h in antibiotic-free RPMI-1640 medium, or medium containing either P. gingivalis WT or SL-null OMVs (1,000 OMVs/cell). Culture supernatant fluids were removed, the THP-1 cells were lysed using Qiagen RLT lysis buffer (Germantown, MD), and cell lysates were stored frozen at −80°C until use. mRNA was isolated and purified from the cell lysates using RNeasy Plus Mini Kits (Qiagen; Germantown, MD). Quality assessments of all mRNA samples, library preparation, and paired-end sequencing (length = 101) were performed at UF ICBR Gene Expression and Genotyping Core. The bioinformatics pipeline was run entirely in the U. Florida HiperGator cluster computer. Quality control of raw sequences was conducted with FASTQC (75). Adapter sequences were trimmed with Cutadapt (76), sequences with length less than 75 nucleotides were removed, and 5′ and 3′ end bases with Phred score less than 30 were trimmed. Raw trimmed sequences were then mapped to the Homo sapiens GRCh38 primary reference genome (BioProject PRJNA31257). Local mapping of the curated reads was done with BWA-mem (77). Handling, sorting, and conversion of the alignment files was executed with the Samtools suite (78). Finally, the counts of transcripts along the reference genomes were conducted with HTSeq-count (79). Count files from all samples were parsed together in a matrix as input for the statistical and cluster analysis in R (80). Statistical analysis was conducted with the “edgeR” (81). Plotting was done with the “plot” base functions and the package “ggplot2” (82). Pathway and Gene Ontology analyses were conducted using the packages clusterProfiler (83) and pathview (84). Heatmap was generated with the package pheatmap (85).
Statistical analysis
Experiments consisted of two to five biological replicates. Statistical analysis of data sets included the use of unpaired t-test using GraphPad Prism 10 software (GraphPad, San Diego, CA), and unless otherwise indicated, data are presented as means ± SEM. A P < 0.05 was considered significant.
ACKNOWLEDGMENTS
We acknowledge Karen L. Kelley for assisting with Electron Microscopy and Mariza Miranda for assisting with the analysis of OMVs at the University of Florida Interdisciplinary Center for Biotechnology Research (UF ICBR) Electron Microscopy Core, RRID:SCR_019146, and Cytometry Core, RRID:SCR_019119. These studies were supported by PHS/NIDCR grants 1R01DE031159 (F.C.G./M.E.D.), F31DE033255 (Z.G.E.), and T90DE021990.
Contributor Information
Frank C. Gibson, III, Email: fgibson@dental.ufl.edu.
Igor E. Brodsky, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, USA
DATA AVAILABILITY
Gene expression data have been deposited in the NCBI Gene Expression Omnibus (GEO) database (https://www.ncbi.nlm.nih.gov/geo/) under GEO Series accession number GSE313285.
SUPPLEMENTAL MATERIAL
The following material is available online at https://doi.org/10.1128/iai.00736-25.
Fig. S1 to S6; Tables S1 to S9.
ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse.
REFERENCES
- 1. Harrison PJ, Dunn TM, Campopiano DJ. 2018. Sphingolipid biosynthesis in man and microbes. Nat Prod Rep 35:921–954. doi: 10.1039/c8np00019k [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Heaver SL, Johnson EL, Ley RE. 2018. Sphingolipids in host-microbial interactions. Curr Opin Microbiol 43:92–99. doi: 10.1016/j.mib.2017.12.011 [DOI] [PubMed] [Google Scholar]
- 3. Brown EM, Ke X, Hitchcock D, Jeanfavre S, Avila-Pacheco J, Nakata T, Arthur TD, Fornelos N, Heim C, Franzosa EA, Watson N, Huttenhower C, Haiser HJ, Dillow G, Graham DB, Finlay BB, Kostic AD, Porter JA, Vlamakis H, Clish CB, Xavier RJ. 2019. Bacteroides-derived sphingolipids are critical for maintaining intestinal homeostasis and symbiosis. Cell Host & Microbe 25:668–680. doi: 10.1016/j.chom.2019.04.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Nichols FC, Yao X, Bajrami B, Downes J, Finegold SM, Knee E, Gallagher JJ, Housley WJ, Clark RB. 2011. Phosphorylated dihydroceramides from common human bacteria are recovered in human tissues. PLoS One 6:e16771. doi: 10.1371/journal.pone.0016771 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ. 2012. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res 91:914–920. doi: 10.1177/0022034512457373 [DOI] [PubMed] [Google Scholar]
- 6. Hajishengallis G. 2015. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol 15:30–44. doi: 10.1038/nri3785 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Golub LM, Lee HM, Bacigalupo J, Gu Y. 2024. Host modulation therapy in periodontitis, diagnosis and treatment-status update. Front Dent Med 5:1423401. doi: 10.3389/fdmed.2024.1423401 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Bhuyan R, Bhuyan SK, Mohanty JN, Das S, Juliana N, Juliana IF. 2022. Periodontitis and its inflammatory changes linked to various systemic diseases: a review of its underlying mechanisms. Biomedicines 10:2659. doi: 10.3390/biomedicines10102659 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Kinane DF, Stathopoulou PG, Papapanou PN. 2017. Periodontal diseases. Nat Rev Dis Primers 3:17038. doi: 10.1038/nrdp.2017.38 [DOI] [PubMed] [Google Scholar]
- 10. Poole S, Singhrao SK, Chukkapalli S, Rivera M, Velsko I, Kesavalu L, Crean S. 2015. Active invasion of porphyromonas gingivalis and infection-induced complement activation in ApoE-/- mice brains. J Alzheimers Dis 43:67–80. doi: 10.3233/JAD-140315 [DOI] [PubMed] [Google Scholar]
- 11. Kozarov EV, Dorn BR, Shelburne CE, Dunn WA, Progulske-Fox A. 2005. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler Thromb Vasc Biol 25:e17–8. doi: 10.1161/01.ATV.0000155018.67835.1a [DOI] [PubMed] [Google Scholar]
- 12. Nagaoka K, Yanagihara K, Harada Y, Yamada K, Migiyama Y, Morinaga Y, Izumikawa K, Kohno S. 2017. Quantitative detection of periodontopathic bacteria in lower respiratory tract specimens by real-time PCR. J Infect Chemother 23:69–73. doi: 10.1016/j.jiac.2016.09.013 [DOI] [PubMed] [Google Scholar]
- 13. Rocha FG, Moye ZD, Ottenberg G, Tang P, Campopiano DJ, Gibson FC III, Davey ME. 2020. Porphyromonas gingivalis sphingolipid synthesis limits the host inflammatory response. J Dent Res 99:568–576. doi: 10.1177/0022034520908784 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Nichols FC, Riep B, Mun J, Morton MD, Bojarski MT, Dewhirst FE, Smith MB. 2004. Structures and biological activity of phosphorylated dihydroceramides of Porphyromonas gingivalis. J Lipid Res 45:2317–2330. doi: 10.1194/jlr.M400278-JLR200 [DOI] [PubMed] [Google Scholar]
- 15. Moye ZD, Valiuskyte K, Dewhirst FE, Nichols FC, Davey ME. 2016. Synthesis of Sphingolipids impacts survival of Porphyromonas gingivalis and the presentation of surface polysaccharides. Front Microbiol 7:1919. doi: 10.3389/fmicb.2016.01919 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Nichols FC, Clark RB, Liu Y, Provatas AA, Dietz CJ, Zhu Q, Wang YH, Smith MB. 2020. Glycine lipids of Porphyromonas gingivalis are agonists for toll-like receptor 2. Infect Immun 88:e00877-19. doi: 10.1128/IAI.00877-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Nichols FC, Bhuse K, Clark RB, Provatas AA, Carrington E, Wang YH, Zhu Q, Davey ME, Dewhirst FE. 2021. Serine/glycine lipid recovery in lipid extracts from healthy and diseased dental samples: relationship to chronic periodontitis. Front Oral Health 2:698481. doi: 10.3389/froh.2021.698481 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Oner F, Yu M, Rivas CA, Greatorex J, Zimmerman P, Guney Z, Irimia D, Davey ME, Kantarci A. 2025. Porphyromonas gingivalis sphingolipids impair neutrophil function and promote bacterial survival. J Oral Microbiol 17:2579103. doi: 10.1080/20002297.2025.2579103 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Aleksijević LH, Aleksijević M, Škrlec I, Šram M, Šram M, Talapko J. 2022. Porphyromonas gingivalis virulence factors and clinical significance in periodontal disease and coronary artery diseases. Pathogens 11:1173. doi: 10.3390/pathogens11101173 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Cecil JD, Sirisaengtaksin N, O’Brien-Simpson NM, Krachler AM. 2019. Outer membrane vesicle-host cell interactions. Microbiol Spectr 7. doi: 10.1128/microbiolspec.psib-0001-2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Schwechheimer C, Kuehn MJ. 2015. Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions. Nat Rev Microbiol 13:605–619. doi: 10.1038/nrmicro3525 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Nice JB, Collins SM, Agro SMJ, Sinani A, Moros SD, Pasch LM, Brown AC. 2024. Heterogeneity of size and toxin distribution in Aggregatibacter actinomycetemcomitans outer membrane vesicles. Toxins (Basel) 16:138. doi: 10.3390/toxins16030138 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Ho M-H, Chen C-H, Goodwin JS, Wang B-Y, Xie H. 2015. Functional advantages of Porphyromonas gingivalis vesicles. PLoS ONE 10:e0123448. doi: 10.1371/journal.pone.0123448 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Gui MJ, Dashper SG, Slakeski N, Chen Y-Y, Reynolds EC. 2016. Spheres of influence: porphyromonas gingivalis outer membrane vesicles. Mol Oral Microbiol 31:365–378. doi: 10.1111/omi.12134 [DOI] [PubMed] [Google Scholar]
- 25. Rocha FG, Ottenberg G, Eure ZG, Davey ME, Gibson FC. 2021. Sphingolipid-containing outer membrane vesicles serve as a delivery vehicle to limit macrophage immune response to Porphyromonas gingivalis. Infect Immun 89. doi: 10.1128/IAI.00614-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Cecil JD, O’Brien-Simpson NM, Lenzo JC, Holden JA, Chen YY, Singleton W, Gause KT, Yan Y, Caruso F, Reynolds EC. 2016. Differential responses of pattern recognition receptors to outer membrane vesicles of three periodontal pathogens. PLoS One 11:e0151967. doi: 10.1371/journal.pone.0151967 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Burns E, Eliyahu T, Uematsu S, Akira S, Nussbaum G. 2010. TLR2-dependent inflammatory response to Porphyromonas gingivalis is MyD88 independent, whereas MyD88 is required to clear infection. J Immunol 184:1455–1462. doi: 10.4049/jimmunol.0900378 [DOI] [PubMed] [Google Scholar]
- 28. Wara-aswapati N, Chayasadom A, Surarit R, Pitiphat W, Boch JA, Nagasawa T, Ishikawa I, Izumi Y. 2013. Induction of toll-like receptor expression by Porphyromonas gingivalis. J Periodontol 84:1010–1018. doi: 10.1902/jop.2012.120362 [DOI] [PubMed] [Google Scholar]
- 29. Maekawa T, Krauss JL, Abe T, Jotwani R, Triantafilou M, Triantafilou K, Hashim A, Hoch S, Curtis MA, Nussbaum G, Lambris JD, Hajishengallis G. 2014. Porphyromonas gingivalis manipulates complement and TLR signaling to uncouple bacterial clearance from inflammation and promote dysbiosis. Cell Host Microbe 15:768–778. doi: 10.1016/j.chom.2014.05.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Hajishengallis G, Wang M, Liang S, Triantafilou M, Triantafilou K. 2008. Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function. Proc Natl Acad Sci U S A 105:13532–13537. doi: 10.1073/pnas.0803852105 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Jia L, Han N, Du J, Guo L, Luo Z, Liu Y. 2019. Pathogenesis of important virulence factors of Porphyromonas gingivalis via toll-like receptors. Front Cell Infect Microbiol 9:262. doi: 10.3389/fcimb.2019.00262 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Tsuda K, Amano A, Umebayashi K, Inaba H, Nakagawa I, Nakanishi Y, Yoshimori T. 2005. Molecular dissection of internalization of Porphyromonas gingivalis by cells using fluorescent beads coated with bacterial membrane vesicle. Cell Struct Funct 30:81–91. doi: 10.1247/csf.30.81 [DOI] [PubMed] [Google Scholar]
- 33. Furuta N, Tsuda K, Omori H, Yoshimori T, Yoshimura F, Amano A. 2009. Porphyromonas gingivalis outer membrane vesicles enter human epithelial cells via an endocytic pathway and are sorted to lysosomal compartments. Infect Immun 77:4187–4196. doi: 10.1128/IAI.00009-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Chuang WC, Yang CN, Wang HW, Lin SK, Yu CC, Syu JH, Chiang CP, Shiao YJ, Chen YW. 2024. The mechanisms of Porphyromonas gingivalis-derived outer membrane vesicles-induced neurotoxicity and microglia activation. J Dent Sci 19:1434–1442. doi: 10.1016/j.jds.2024.04.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Navarrete M, García J, Dutzan N, Henríquez L, Puente J, Carvajal P, Hernandez M, Gamonal J. 2014. Interferon-γ, interleukins-6 and -4, and factor XIII-A as indirect markers of the classical and alternative macrophage activation pathways in chronic periodontitis. J Periodontol 85:751–760. doi: 10.1902/jop.2013.130078 [DOI] [PubMed] [Google Scholar]
- 36. Lam RS, O’Brien-Simpson NM, Lenzo JC, Holden JA, Brammar GC, Walsh KA, McNaughtan JE, Rowler DK, Van Rooijen N, Reynolds EC. 2014. Macrophage depletion abates Porphyromonas gingivalis-induced alveolar bone resorption in mice. J Immunol 193:2349–2362. doi: 10.4049/jimmunol.1400853 [DOI] [PubMed] [Google Scholar]
- 37. Parker H, Chitcholtan K, Hampton MB, Keenan JI. 2010. Uptake of Helicobacter pylori outer membrane vesicles by gastric epithelial cells. Infect Immun 78:5054–5061. doi: 10.1128/iai.00299-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Mohtasebi MS, Nasri F, Kamali Sarvestani E. 2014. Effect of DiD carbocyanine dye labeling on immunoregulatory function and differentiation of mice mesenchymal stem cells. Stem Cells Int 2014:457614. doi: 10.1155/2014/457614 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Jones EJ, Booth C, Fonseca S, Parker A, Cross K, Miquel-Clopés A, Hautefort I, Mayer U, Wileman T, Stentz R, Carding SR. 2020. The uptake, trafficking, and biodistribution of Bacteroides thetaiotaomicron generated outer membrane vesicles. Front Microbiol 11:57. doi: 10.3389/fmicb.2020.00057 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Mulcahy LA, Pink RC, Carter DRF. 2014. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles 3:24641. doi: 10.3402/jev.v3.24641 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Lulevich V, Shih Y-P, Lo SH, Liu G-Y. 2009. Cell tracing dyes significantly change single cell mechanics. J Phys Chem B 113:6511–6519. doi: 10.1021/jp8103358 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Ismail S, Hampton MB, Keenan JI. 2003. Helicobacter pylori outer membrane vesicles modulate proliferation and interleukin-8 production by gastric epithelial cells. Infect Immun 71:5670–5675. doi: 10.1128/IAI.71.10.5670-5675.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Brown EM, Temple ER, Jeanfavre S, Avila-Pacheco J, Taylor N, Liu K, Nguyen PNU, Mohamed AMT, Ung P, Walker RA, Graham DB, Clish CB, Xavier RJ. 2025. Bacteroides sphingolipids promote anti-inflammatory responses through the mevalonate pathway. Cell Host Microbe 33:901–914. doi: 10.1016/j.chom.2025.05.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Fleetwood AJ, Lee MKS, Singleton W, Achuthan A, Lee MC, O’Brien-Simpson NM, Cook AD, Murphy AJ, Dashper SG, Reynolds EC, Hamilton JA. 2017. Metabolic remodeling, inflammasome activation, and pyroptosis in macrophages stimulated by Porphyromonas gingivalis and its outer membrane vesicles. Front Cell Infect Microbiol 7:351. doi: 10.3389/fcimb.2017.00351 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. O’Donoghue EJ, Krachler AM. 2016. Mechanisms of outer membrane vesicle entry into host cells. Cell Microbiol 18:1508–1517. doi: 10.1111/cmi.12655 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Elmi A, Watson E, Sandu P, Gundogdu O, Mills DC, Inglis NF, Manson E, Imrie L, Bajaj-Elliott M, Wren BW, Smith DGE, Dorrell N. 2012. Campylobacter jejuni outer membrane vesicles play an important role in bacterial interactions with human intestinal epithelial cells. Infect Immun 80:4089–4098. doi: 10.1128/IAI.00161-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Pollak CN, Delpino MV, Fossati CA, Baldi PC. 2012. Outer membrane vesicles from Brucella abortus promote bacterial internalization by human monocytes and modulate their innate immune response. PLoS One 7:e50214. doi: 10.1371/journal.pone.0050214 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Olsen I, Nichols FC. 2018. Are sphingolipids and serine dipeptide lipids underestimated virulence factors of Porphyromonas gingivalis? Infect Immun 86:e00035-18. doi: 10.1128/IAI.00035-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Nichols FC, Riep B, Mun J, Morton MD, Kawai T, Dewhirst FE, Smith MB. 2006. Structures and biological activities of novel phosphatidylethanolamine lipids of Porphyromonas gingivalis. J Lipid Res 47:844–853. doi: 10.1194/jlr.M500542-JLR200 [DOI] [PubMed] [Google Scholar]
- 50. Kanzaki H, Movila A, Kayal R, Napimoga MH, Egashira K, Dewhirst F, Sasaki H, Howait M, Al-Dharrab A, Mira A, Han X, Taubman MA, Nichols FC, Kawai T. 2017. Phosphoglycerol dihydroceramide, a distinctive ceramide produced by Porphyromonas gingivalis, promotes RANKL-induced osteoclastogenesis by acting on non-muscle myosin II-A (Myh9), an osteoclast cell fusion regulatory factor. Biochim Biophys Acta Mol Cell Biol Lipids 1862:452–462. doi: 10.1016/j.bbalip.2017.01.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Zahlten J, Riep B, Nichols FC, Walter C, Schmeck B, Bernimoulin JP, Hippenstiel S. 2007. Porphyromonas gingivalis dihydroceramides induce apoptosis in endothelial cells. J Dent Res 86:635–640. doi: 10.1177/154405910708600710 [DOI] [PubMed] [Google Scholar]
- 52. An D, Oh SF, Olszak T, Neves JF, Avci FY, Erturk-Hasdemir D, Lu X, Zeissig S, Blumberg RS, Kasper DL. 2014. Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells. Cell 156:123–133. doi: 10.1016/j.cell.2013.11.042 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Wang YH, Jiang J, Zhu Q, AlAnezi AZ, Clark RB, Jiang X, Rowe DW, Nichols FC. 2010. Porphyromonas gingivalis lipids inhibit osteoblastic differentiation and function. Infect Immun 78:3726–3735. doi: 10.1128/IAI.00225-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Nichols FC, Clark RB, Maciejewski MW, Provatas AA, Balsbaugh JL, Dewhirst FE, Smith MB, Rahmlow A. 2020. A novel phosphoglycerol serine-glycine lipodipeptide of Porphyromonas gingivalis is a TLR2 ligand. J Lipid Res 61:1645–1657. doi: 10.1194/jlr.RA120000951 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Cecil JD, O’Brien-Simpson NM, Lenzo JC, Holden JA, Singleton W, Perez-Gonzalez A, Mansell A, Reynolds EC. 2017. Outer membrane vesicles prime and activate macrophage inflammasomes and cytokine secretion in vitro and in vivo. Front Immunol 8:1017. doi: 10.3389/fimmu.2017.01017 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. O’Donoghue EJ, Sirisaengtaksin N, Browning DF, Bielska E, Hadis M, Fernandez-Trillo F, Alderwick L, Jabbari S, Krachler AM. 2017. Lipopolysaccharide structure impacts the entry kinetics of bacterial outer membrane vesicles into host cells. PLoS Pathog 13:e1006760. doi: 10.1371/journal.ppat.1006760 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Wielento A, Bereta GP, Łagosz-Ćwik KB, Eick S, Lamont RJ, Grabiec AM, Potempa J. 2022. TLR2 Activation by Porphyromonas gingivalis requires both PPAD activity and fimbriae. Front Immunol 13:823685. doi: 10.3389/fimmu.2022.823685 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Wallet SM, Puri V, Gibson FC. 2018. Linkage of infection to adverse systemic complications: periodontal disease, toll-like receptors, and other pattern recognition systems. Vaccines (Basel) 6:21. doi: 10.3390/vaccines6020021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Papadopoulos G, Weinberg EO, Massari P, Gibson FC III, Wetzler LM, Morgan EF, Genco CA. 2013. Macrophage-specific TLR2 signaling mediates pathogen-induced TNF-dependent inflammatory oral bone loss. J Immunol 190:1148–1157. doi: 10.4049/jimmunol.1202511 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Mizraji G, Nassar M, Segev H, Sharawi H, Eli-Berchoer L, Capucha T, Nir T, Tabib Y, Maimon A, Dishon S, Shapira L, Nussbaum G, Wilensky A, Hovav AH. 2017. Porphyromonas gingivalis promotes unrestrained type i interferon production by dysregulating TAM signaling via MYD88 degradation. Cell Rep 18:419–431. doi: 10.1016/j.celrep.2016.12.047 [DOI] [PubMed] [Google Scholar]
- 61. Wang M, Krauss JL, Domon H, Hosur KB, Liang S, Magotti P, Triantafilou M, Triantafilou K, Lambris JD, Hajishengallis G. 2010. Microbial hijacking of complement-toll-like receptor crosstalk. Sci Signal 3:ra11. doi: 10.1126/scisignal.2000697 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat Rev Immunol 4:499–511. doi: 10.1038/nri1391 [DOI] [PubMed] [Google Scholar]
- 63. Alaei SR, King AJ, Banani K, Reddy A, Ortiz J, Knight AL, Haldeman J, Su TH, Park H, Coats SR, Jain S. 2025. Lipid a remodeling modulates outer membrane vesicle biogenesis by Porphyromonas gingivalis. J Bacteriol 207:e0033624. doi: 10.1128/jb.00336-24 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Coats SR, Kantrong N, To TT, Jain S, Genco CA, McLean JS, Darveau RP. 2019. The distinct immune-stimulatory capacities of Porphyromonas gingivalis strains 381 and ATCC 33277 are determined by the fimB allele and gingipain activity. Infect Immun 87:e00319-19. doi: 10.1128/IAI.00319-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Marchesan JT, Morelli T, Lundy SK, Jiao Y, Lim S, Inohara N, Nunez G, Fox DA, Giannobile WV. 2012. Divergence of the systemic immune response following oral infection with distinct strains of Porphyromonas gingivalis. Mol Oral Microbiol 27:483–495. doi: 10.1111/omi.12001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Wai SN, Lindmark B, Söderblom T, Takade A, Westermark M, Oscarsson J, Jass J, Richter-Dahlfors A, Mizunoe Y, Uhlin BE. 2003. Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin. Cell 115:25–35. doi: 10.1016/s0092-8674(03)00754-2 [DOI] [PubMed] [Google Scholar]
- 67. Karthikeyan R, Gayathri P, Ramasamy S, Suvekbala V, Jagannadham MV, Rajendhran J. 2023. Transcriptome responses of intestinal epithelial cells induced by membrane vesicles of Listeria monocytogenes. Current Research in Microbial Sciences 4:100185. doi: 10.1016/j.crmicr.2023.100185 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Castillo Y, Castellanos JE, Lafaurie GI, Castillo DM. 2022. Porphyromonas gingivalis outer membrane vesicles modulate cytokine and chemokine production by gingipain-dependent mechanisms in human macrophages. Arch Oral Biol 140:105453. doi: 10.1016/j.archoralbio.2022.105453 [DOI] [PubMed] [Google Scholar]
- 69. Kuboniwa M, Hasegawa Y, Mao S, Shizukuishi S, Amano A, Lamont RJ, Yilmaz O. 2008. P. gingivalis accelerates gingival epithelial cell progression through the cell cycle. Microbes Infect 10:122–128. doi: 10.1016/j.micinf.2007.10.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Kobayashi T, Yoshie H. 2015. Host responses in the link between periodontitis and rheumatoid arthritis. Curr Oral Health Rep 2:1–8. doi: 10.1007/s40496-014-0039-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Kobayashi T, Okada M, Ito S, Kobayashi D, Ishida K, Kojima A, Narita I, Murasawa A, Yoshie H. 2014. Assessment of interleukin‐6 receptor inhibition therapy on periodontal condition in patients with rheumatoid arthritis and chronic periodontitis. J Periodontol 85:57–67. doi: 10.1902/jop.2013.120696 [DOI] [PubMed] [Google Scholar]
- 72. Johnson EL, Heaver SL, Waters JL, Kim BI, Bretin A, Goodman AL, Gewirtz AT, Worgall TS, Ley RE. 2020. Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels. Nat Commun 11:2471. doi: 10.1038/s41467-020-16274-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. Bae S, Park PSU, Lee Y, Mun SH, Giannopoulou E, Fujii T, Lee KP, Violante SN, Cross JR, Park-Min K-H. 2021. MYC-mediated early glycolysis negatively regulates proinflammatory responses by controlling IRF4 in inflammatory macrophages. Cell Rep 35:109264. doi: 10.1016/j.celrep.2021.109264 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74. Kolliniati O, Ieronymaki E, Vergadi E, Tsatsanis C. 2022. Metabolic regulation of macrophage activation. J Innate Immun 14:51–68. doi: 10.1159/000516780 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. Andrews S. 2015. FASTQC: a quality control tool for high throughput sequence data., Babraham Institute . Available from: https://www.bioinformatics.babraham.ac.uk/projects/fastqc
- 76. Martin M. 2011. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J 17:10. doi: 10.14806/ej.17.1.200 [DOI] [Google Scholar]
- 77. Li H, Durbin R. 2009. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25:1754–1760. doi: 10.1093/bioinformatics/btp324 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R, Subgroup GPDP. 2009. The sequence alignment/Map format and SAMtools. Bioinformatics 25:2078–2079. doi: 10.1093/bioinformatics/btp352 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79. Anders S, Pyl PT, Huber W. 2015. HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics 31:166–169. doi: 10.1093/bioinformatics/btu638 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80. Team DPRDC. 2010. R: A language and environment for statistical computing, version 4.5.2. Vienna, Austria. https://www.R-project.org. [Google Scholar]
- 81. Robinson MD, McCarthy DJ, Smyth GK. 2010. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26:139–140. doi: 10.1093/bioinformatics/btp616 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82. Wickham H. 2016. Ggplot2: elegant graphics for data analysis. 2nd ed. Springer Publishing Company, Incorporated, New York, NY. [Google Scholar]
- 83. Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, Fu X, Liu S, Bo X, Yu G. 2021. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. The Innovation 2:100141. doi: 10.1016/j.xinn.2021.100141 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84. Luo W, Brouwer C. 2013. Pathview: an R/Bioconductor package for pathway-based data integration and visualization. Bioinformatics 29:1830–1831. doi: 10.1093/bioinformatics/btt285 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85. Kolde R. 2019. Pheatmap: Pretty Heatmaps. R package version 1.0.13. Comprehensive R Achive Network (CRAN), Vienna, Austria. https://cran.r-project.org/web/packages/pheatmap/index.html. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Fig. S1 to S6; Tables S1 to S9.
Data Availability Statement
Gene expression data have been deposited in the NCBI Gene Expression Omnibus (GEO) database (https://www.ncbi.nlm.nih.gov/geo/) under GEO Series accession number GSE313285.
